Similar content being viewed by others
This article is cited by
-
Mucopolysaccharidoses and the blood–brain barrier
Fluids and Barriers of the CNS (2022)
-
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
Orphanet Journal of Rare Diseases (2018)
-
Evaluation of enzyme dose and dose‐frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain
Journal of Inherited Metabolic Disease (2015)
-
Immune response to intrathecal enzyme replacement therapy in mucopolysaccharidosis I patients
Pediatric Research (2013)